Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study. Biomol Biomed [Internet]. 2018 May 20 [cited 2024 Apr. 28];18(2):185-90. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/2279